Nodal Therapeutics
Silver Spring, US · Founded 2024 · Delaware corporation · 1 known investors
Founders & leadership
JS
Jonathan S. BrombergNamed on SEC filing
CJ
Christopher JewellNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2024
▶$250KraisedOct 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedOct 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan S. BrombergExecutive Officer
- Christopher JewellExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Nodal Therapeutics's investors?
- Nodal Therapeutics's investors include TEDCO.
- How much funding has Nodal Therapeutics raised?
- Nodal Therapeutics has disclosed $250K raised across 1 round.
- Where is Nodal Therapeutics headquartered?
- Nodal Therapeutics is headquartered in Silver Spring, US.